Travoprost Ophthalmic Solution shortage
To Be Discontinued 2 presentations · 1 manufacturers · first FDA posting Jul 7, 2026 · last update Jul 7, 2026
Manufacturers: Mylan Pharmaceuticals Inc., a Viatris Company
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Travoprost, Ophthalmic Solution, 0.004%, 2.5 mL (NDC 0378-9651-32) | Mylan Pharmaceuticals Inc., a Viatris Company | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Jul 7, 2026 Updated Jul 7, 2026 Discontinued Jul 7, 2026 |
| Travoprost, Ophthalmic Solution, 0.004%, 5 mL (NDC 0378-9651-50) | Mylan Pharmaceuticals Inc., a Viatris Company | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Jul 7, 2026 Updated Jul 7, 2026 Discontinued Jul 7, 2026 |